Treace Medical Concepts, Inc. announced that Julie Dewey will join the Company as Chief Communications and Investor Relations Officer, effective July 17, 2023. In this new position, Ms. Dewey will lead all aspects of Treaces corporate communications and investor relations engagement, with a focus on expanding the company's outreach with the investment community and broadening the Company's relationships with key stakeholders, including current and potential investors, securities analysts, and the media. Ms. Dewey joins Treace with extensive experience in the medical device industry, including senior leadership roles in Investor Relations, Corporate Communications and Marketing, most recently as Chief Corporate Communications and IR Officer for Nevro Corp.

Prior to Nevro, she was Senior Vice President and Chief Communications Officer of Wright Medical Group, N.V., a leading orthopaedic company focused on extremities and biologics, which was acquired by Stryker. While at Wright, she built a world-class investor relations program that was the highest ranked small-mid cap medical device IR program by Institutional Investor for a record five consecutive years. Earlier in her career, Ms. Dewey held investor relations and marketing positions at ev3 Inc. (acquired by Covidien/Medtronic), Kyphon Inc. (acquired by Medtronic) and Thoratec Corporation (acquired by St.

Jude/Abbott). Ms. Dewey received a B.S. degree in business administration from the University of Southern California and an M.B.A. from Pepperdine University.